Samsung Medical Center Amyloid PET Cohort (SMC Amyloid PET)
The SMC Amyloid PET study began in 2016 and aimed to verify the predictive effect of amyloid-pathology (amyloid-PET imaging) and biomarkers from participants who had been followed up for more than 5 years. The study included 6 participant groups: Alzheimer’s disease, dementia, amnestic mild cognitive impairment, elderly controls, young controls, subcortical vascular cognitive impairment, and cerebral amyloid angiopathy. All participants were recruited from Samsung Medical Center (SMC) in South Korea.
Study design
Cohort, Cohort - clinical
Number of participants at first data collection
120 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2016
Primary Institutions
Samsung Medical Center (SMC)
Profile paper DOI
Funders
Division of Intelligent Precision Healthcare
Korea Dementia Research Center (KDRC)
Korea Health Industry Development Institute (KHIDI)
Medical Research Council (MRC)
Ministry of Health and Welfare (보건복지부, MOHW)
Ongoing?
No
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- None
Engagement
Keywords
